| Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers (NCT07243015) | City of Hope Medical Center | 2025-01-15 |
| An Exosomal microRNA Signature for Preoperative Staging in Colon Cancer (NCT07255729) | City of Hope Medical Center | 2025-01-15 |
| Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA (NCT07224789) | City of Hope Medical Center | 2025-01-15 |
| Integrated Cf-miRNA and Exosomal miRNA Signature for Early Detection of Esophageal Squamous Cell Carcinoma (NCT07266363) | City of Hope Medical Center | 2025-01-15 |
| Telehealth Intervention for Ostomy Self-Management (NCT06528990) | City of Hope Medical Center | 2025-01-02 |
| CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS (NCT06252402) | City of Hope Medical Center | 2024-12-19 |
| Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy (NCT06763328) | City of Hope Medical Center | 2024-12-16 |
| A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab (NCT07003100) | City of Hope Medical Center | 2024-12-06 |
| Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant (NCT06575296) | City of Hope Medical Center | 2024-12-06 |
| Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (NCT06054776) | City of Hope Medical Center | 2024-12-02 |
| Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma (NCT05773664) | City of Hope Medical Center | 2024-11-15 |
| A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia (NCT05757310) | City of Hope Medical Center | 2024-11-15 |
| Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer (NCT07226154) | City of Hope Medical Center | 2024-11-15 |
| Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia (NCT06447987) | City of Hope Medical Center | 2024-11-06 |
| Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Metastatic Microsatellite Stable Colorectal Cancer (NCT06575725) | City of Hope Medical Center | 2024-11-01 |
| Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDS (NCT05823480) | City of Hope Medical Center | 2024-10-09 |
| Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma (NCT06014827) | City of Hope Medical Center | 2024-10-09 |
| PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer (NCT05805371) | City of Hope Medical Center | 2024-10-09 |
| On the BRINK: PhotoBiomodulation (PBM) for Mucositis in Patients Undergoing Allogeneic Hematopoietic Stem Cell TRansplant (HSCT) - Implementing the Evidence & Discovering New Knowledge (NCT06625619) | City of Hope Medical Center | 2024-10-07 |
| Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers (NCT06524973) | City of Hope Medical Center | 2024-10-07 |
| Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial (NCT06042569) | City of Hope Medical Center | 2024-09-16 |
| Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma (NCT06453044) | City of Hope Medical Center | 2024-09-09 |
| Denosumab for Type 1 Diabetes (NCT06524960) | City of Hope Medical Center | 2024-09-03 |
| High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer (NCT06538389) | City of Hope Medical Center | 2024-08-26 |
| Aromatherapy Oil Associated for Managing Anxiety and Pain During Bone Marrow Biopsy Procedures (NCT06581211) | City of Hope Medical Center | 2024-08-23 |
| Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases (NCT06549478) | City of Hope Medical Center | 2024-07-26 |
| Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer (NCT06260033) | City of Hope Medical Center | 2024-07-23 |
| e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study (NCT05786456) | City of Hope Medical Center | 2024-07-19 |
| Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome (NCT06128070) | City of Hope Medical Center | 2024-07-16 |
| Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation (NCT06440850) | City of Hope Medical Center | 2024-07-15 |
| CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant (NCT06059391) | City of Hope Medical Center | 2024-07-12 |
| Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy (NCT05869682) | City of Hope Medical Center | 2024-07-09 |
| Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors (NCT05672342) | City of Hope Medical Center | 2024-07-06 |
| Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer (NCT07664579) | City of Hope Medical Center | 2024-07-05 |
| Electron Beam Radiotherapy for the Treatment of Refractory Sclerodermatous Chronic Graft Versus Host Disease (NCT05515692) | City of Hope Medical Center | 2024-06-30 |
| Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer (NCT06408220) | City of Hope Medical Center | 2024-06-27 |
| A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer (NCT07224750) | City of Hope Medical Center | 2024-06-21 |
| An Exosomal miRNA-based Liquid Biopsy for ICC Detection (NCT07225452) | City of Hope Medical Center | 2024-06-21 |
| Splicing-based Predictive Learning for Individual Chemotherapy Evaluation in Colorectal Cancer (NCT07226115) | City of Hope Medical Center | 2024-06-21 |
| Epigenetic Signature for CRC Early Detection (NCT07224854) | City of Hope Medical Center | 2024-06-21 |
| Forecasting Occult liveR Metastasis Using an Exosomal Signature for Intelligent Guided Hepatic Targeting (NCT07224802) | City of Hope Medical Center | 2024-06-21 |
| Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC (NCT07224841) | City of Hope Medical Center | 2024-06-21 |
| cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal Cancer (NCT07224815) | City of Hope Medical Center | 2024-06-21 |
| Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma. (NCT07224737) | City of Hope Medical Center | 2024-06-21 |
| Comparing the Impact of Four Types of Meditation Practices for Relaxation in Cancer Survivors (NCT06500377) | City of Hope Medical Center | 2024-06-17 |
| Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases (NCT07224724) | City of Hope Medical Center | 2024-06-01 |
| Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome (NCT06195891) | City of Hope Medical Center | 2024-05-24 |
| Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy (NCT06139627) | City of Hope Medical Center | 2024-05-21 |
| Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer (NCT06454383) | City of Hope Medical Center | 2024-05-13 |
| The da Vinci Single Port Robotic System for Use in Abdominal and Pelvic Surgical Procedures (NCT05672368) | City of Hope Medical Center | 2024-04-26 |
| Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer (NCT06249282) | City of Hope Medical Center | 2024-04-24 |
| Passive Music Intervention for the Reduction of Anxiety in Patients Undergoing Bone Marrow Aspiration and/or Biopsy (NCT06169267) | City of Hope Medical Center | 2024-04-22 |
| Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma (NCT06048250) | City of Hope Medical Center | 2024-04-09 |
| An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer (NCT06342414) | City of Hope Medical Center | 2024-03-15 |
| Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation (NCT05993611) | City of Hope Medical Center | 2024-02-19 |
| Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma (NCT06112847) | City of Hope Medical Center | 2024-01-24 |
| Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (NCT05672251) | City of Hope Medical Center | 2024-01-02 |
| CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia (NCT05672147) | City of Hope Medical Center | 2023-12-07 |
| Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers (NCT06196008) | City of Hope Medical Center | 2023-12-05 |
| Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma (NCT05830058) | City of Hope Medical Center | 2023-11-29 |
| Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma (NCT06049576) | City of Hope Medical Center | 2023-10-06 |
| Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin Lymphoma (NCT05801913) | City of Hope Medical Center | 2023-09-29 |
| Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca (NCT06008158) | City of Hope Medical Center | 2023-09-29 |
| 64Cu-DOTA Pembrolizumab for Imaging Metastatic Solid Tumors in Patients Receiving Stereotactic Body Radiation (NCT05728372) | City of Hope Medical Center | 2023-08-25 |
| Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29 (NCT04670874) | City of Hope Medical Center | 2023-08-17 |
| Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma (NCT05861050) | City of Hope Medical Center | 2023-08-10 |
| A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia (NCT05672355) | City of Hope Medical Center | 2023-08-01 |
| Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma (NCT05432635) | City of Hope Medical Center | 2023-08-01 |
| Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial (NCT06022965) | City of Hope Medical Center | 2023-07-24 |
| Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma (NCT05800405) | City of Hope Medical Center | 2023-07-20 |
| Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma (NCT05625594) | City of Hope Medical Center | 2023-06-29 |
| Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study (NCT06052826) | City of Hope Medical Center | 2023-06-23 |
| Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies (NCT05443425) | City of Hope Medical Center | 2023-06-16 |
| Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation (NCT05672173) | City of Hope Medical Center | 2023-06-02 |
| Impact of the Therapeutic Alliance on Reduction of Disparities in Latino End-of-Life Cancer Care (NCT04342611) | City of Hope Medical Center | 2023-05-19 |
| Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study (NCT05718869) | City of Hope Medical Center | 2023-05-18 |
| Phase II Trial of Lung Chemoemobolization (NCT05672108) | City of Hope Medical Center | 2023-05-12 |
| Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy (NCT05672316) | City of Hope Medical Center | 2023-05-11 |
| FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer (NCT05627635) | City of Hope Medical Center | 2023-05-03 |
| Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas (NCT05139056) | City of Hope Medical Center | 2023-05-02 |
| Tazemetostat in Combination With Umbralisib and Ublituximab for the Treatment Relapsed or Refractory Follicular Lymphoma (NCT05152459) | City of Hope Medical Center | 2023-05-01 |
| Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer (NCT05225363) | City of Hope Medical Center | 2023-05-01 |
| Enasidenib in Combination With Cobimetinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (NCT05441514) | City of Hope Medical Center | 2023-04-28 |
| Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid Tumors (NCT05733949) | City of Hope Medical Center | 2023-04-27 |
| CD19-Car T Cell Therapy for the Treatment of Older Adults With Acute Lymphoblastic Leukemia in First Remission (NCT05707273) | City of Hope Medical Center | 2023-04-26 |
| Early Onset Colorectal Cancer Detection (NCT06342401) | City of Hope Medical Center | 2023-04-15 |
| Early-Onset Colorectal Cancer Recurrence (NCT06271980) | City of Hope Medical Center | 2023-04-15 |
| A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma (NCT06381583) | City of Hope Medical Center | 2023-04-15 |
| Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC) (NCT06381648) | City of Hope Medical Center | 2023-04-15 |
| Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer (NCT06654622) | City of Hope Medical Center | 2023-04-01 |
| Predicting Local and Distant Recurrence in T1 Colorectal Cancer (NCT06314971) | City of Hope Medical Center | 2023-03-15 |
| Stomach Cancer Exosome-based Detection (NCT06342427) | City of Hope Medical Center | 2023-03-15 |
| RefleXion PET/CT Imaging Performance in Patients With Various Malignancies (NCT05844306) | City of Hope Medical Center | 2023-03-15 |
| Stage II/III Colorectal Cancer Recurrence (NCT06314958) | City of Hope Medical Center | 2023-03-15 |
| Pancreatic Cancer Detection Consortium (NCT06388967) | City of Hope Medical Center | 2023-03-15 |
| Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE Study (NCT05772130) | City of Hope Medical Center | 2023-02-14 |
| A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer (NCT05751434) | City of Hope Medical Center | 2023-02-10 |
| Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers (NCT05722288) | City of Hope Medical Center | 2023-01-20 |
| An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis (NCT05376878) | City of Hope Medical Center | 2022-12-21 |
| Portable Scalp Cooling System for the Improvement of Chemotherapy-Induced Hair Loss in Patients With Metastatic Breast Cancer (NCT05533320) | City of Hope Medical Center | 2022-12-14 |